3SBio considering proposal to go private

3SBio Inc. (NASDAQ:SSRX) said it is evaluating a non-binding proposal from CEO and Chairman Jing Lou and CPEChina Fund L.P. to acquire the Chinese biotech for $15 per ADS in cash. The price values 3SBio at about $331.2 million, based on about 22.1 million ADSs outstanding at June 30, 2012. The price is a 23% premium to 3SBio's close of $11.59 on Tuesday, before the offer was made public. 3SBio gained $1.83 (16%) to $13.42 on Wednesday. 3SBio did not provide details in time for publication on Lou's and CPEChina Fund's current ownership stakes. The fund could not be reached for comment. ...